Who
Oliver Rolf Baumann
Director
Company insider
Files Form 4 as: Director, Veraxa Biotech AG.
In numbers
- Trades disclosed
- 2
- Buys
- 1
- Sells
- 0
- Bought
- $150K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 27 Aug 2026
- Last trade
- 27 Aug 2026
- Last filed
- 31 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Aug 2026filed 31 Aug 2026 | VRXA Veraxa Biotech AGBiotechnology | SEC FORM 4 Bought | $75K50,000 at $1.50 | filing |
| 27 Aug 2026filed 31 Aug 2026 | VRXA Veraxa Biotech AGBiotechnology | SEC FORM 4 Bought | $75K50,000 at $1.50 | filing |
News
Veraxa Biotech AG: VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC-ADC Technology at World ADC CongressVRXA · finanznachrichten.de · 13 Oct 2026
0 headlines in the last 90 days name Oliver Rolf Baumann; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.